DalsnaFinance › Analyst accuracy › Jefferies › STAA target
Stifel upgrades STAAR Surgical stock rating on China growth outlook
Jefferies reduced price target to $28 from $29, aligning its outlook with Stifel while maintaining a Hold rating.
A fact about what Jefferies published, as reported by Investing.com, not a recommendation from Dalsna Finance; Jefferies is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.